RX694 RX694 Pill - white capsule/oblong, 14mm
Pill with imprint RX694 RX694 is White, Capsule/Oblong and has been identified as Minocycline Hydrochloride 50 mg. It is supplied by Ranbaxy Pharmaceuticals Inc.
Minocycline is used in the treatment of Bacterial Infection; Acne; Bartonellosis; Bullous Pemphigoid; Actinomycosis and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Minocycline 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for RX694 RX694
Minocycline Hydrochloride
- Imprint
- RX694 RX694
- Strength
- 50 mg
- Color
- White
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Tetracyclines
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Ranbaxy Pharmaceuticals Inc.
- Inactive Ingredients
-
gelatin,
titanium dioxide,
propylene glycol,
shellac,
potassium hydroxide,
corn starch,
ferrosoferric oxide,
magnesium stearate
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
63304-0694 | Ranbaxy Pharmaceuticals Inc. |
13668-0482 | Torrent Pharmaceuticals Limited |
More about minocycline
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (563)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: tetracyclines
- Breastfeeding
- En español
Patient resources
- Minocycline drug information
- Minocycline (Intravenous) (Advanced Reading)
- Minocycline Capsules and Tablets
- Minocycline Extended-Release Tablets
Other brands
Minocin, Solodyn, Dynacin, Minolira, ... +3 more
Professional resources
- Minocycline monograph
- Minocycline (EENT) (AHFS Monograph)
- Minocycline (FDA)
- Minocycline Capsules (FDA)
- Minocycline Extended Release Tablets (FDA)
Other brands
Minocin, Solodyn, Minolira, Minocin for Injection, Ximino
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.